Insider · CIK 0001451612

Booth Bruce

Reports to the SEC for 8 companies · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001451612

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−934 sh	$111.20	−$104K	2,384,685
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−1,498 sh	$108.28	−$162K	465,168
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−5,471 sh	$105.78	−$579K	2,446,453
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−770 sh	$105.78	−$81.5K	471,497
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−19.4K sh	$107.76	−$2.09M	2,412,158
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−2,698 sh	$107.76	−$291K	466,666
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−1,104 sh	$109.75	−$121K	464,064
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−7,602 sh	$110.67	−$841K	2,386,654
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−1,199 sh	$110.67	−$133K	461,951
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−7,833 sh	$109.75	−$860K	2,394,256
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−2,318 sh	$106.63	−$247K	469,101
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−14.8K sh	$106.63	−$1.58M	2,431,577
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−7,723 sh	$110.67	−$855K	2,385,619
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−2,133 sh	$106.63	−$227K	469,364
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−1,688 sh	$108.28	−$183K	464,389
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−157 sh	$111.20	−$17.5K	461,794
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−19.1K sh	$107.76	−$2.06M	2,412,747
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−10.7K sh	$108.28	−$1.15M	2,402,089
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−130 sh	$111.20	−$14.5K	462,856
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−1,078 sh	$110.67	−$119K	462,986
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−1,239 sh	$109.75	−$136K	463,150
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−907 sh	$111.20	−$101K	2,385,747
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−14.6K sh	$106.63	−$1.56M	2,431,840
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−848 sh	$105.78	−$89.7K	471,419
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−3,024 sh	$107.76	−$326K	466,077
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−5,549 sh	$105.78	−$587K	2,446,375
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−10.8K sh	$108.28	−$1.17M	2,401,310
2026-06-29	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−7,968 sh	$109.75	−$874K	2,393,342
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−952 sh	$115.69	−$110K	478,766
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−78 sh	$112.49	−$8,774.22	485,697
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−1,701 sh	$117.09	−$199K	477,065
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−32.4K sh	$108.14	−$3.5M	493,358
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−22K sh	$117.85	−$2.6M	2,464,314
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−4,562 sh	$109.79	−$501K	488,796
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−3,069 sh	$117.85	−$362K	473,996
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−555 sh	$112.49	−$62.4K	2,548,226
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−10.4K sh	$111.51	−$1.16M	2,548,781
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−14.9K sh	$113.97	−$1.7M	2,533,313
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−32.6K sh	$109.79	−$3.58M	2,570,424
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−12.2K sh	$117.09	−$1.43M	2,486,360
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−12.4K sh	$118.66	−$1.47M	2,451,924
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−3,958 sh	$107.57	−$426K	525,760
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−1,579 sh	$110.49	−$174K	487,217
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−1,442 sh	$111.51	−$161K	485,775
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−2,083 sh	$113.97	−$237K	483,614
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−3,896 sh	$114.94	−$448K	479,718
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−231K sh	$108.14	−$25M	2,603,048
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−11.3K sh	$110.49	−$1.25M	2,559,147
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−28K sh	$114.94	−$3.21M	2,505,362
2026-06-26	KYMRKymera Therapeutics, Inc.S Sale	Director	SSale	−28.3K sh	$107.57	−$3.04M	2,834,055

Recent filings

Accepted (ET)
Jul 24/A
Booth Bruce0001451612-26-000022
SEC(opens sec.gov)
Jun 304
Booth Bruce0001451612-26-000018
SEC(opens sec.gov)

Companies

Address

C/O KYMERA THERAPEUTICS, INC. 500 NORTH BEACON STREET, FLOOR 4

WATERTOWN, MA, 02472